nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Dacarbazine—muscle cancer	0.0864	0.213	CbGbCtD
Doxepin—ABCB1—Dactinomycin—muscle cancer	0.0655	0.161	CbGbCtD
Doxepin—CYP1A2—Etoposide—muscle cancer	0.0423	0.104	CbGbCtD
Doxepin—ABCB1—Vincristine—muscle cancer	0.0404	0.0993	CbGbCtD
Doxepin—ABCB1—Etoposide—muscle cancer	0.037	0.091	CbGbCtD
Doxepin—ABCB1—Doxorubicin—muscle cancer	0.0252	0.0621	CbGbCtD
Doxepin—ABCB1—Methotrexate—muscle cancer	0.0244	0.0601	CbGbCtD
Doxepin—CYP3A4—Vincristine—muscle cancer	0.0242	0.0595	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—muscle cancer	0.0238	0.0585	CbGbCtD
Doxepin—CYP3A4—Etoposide—muscle cancer	0.0222	0.0545	CbGbCtD
Doxepin—CHRM3—muscle of abdomen—muscle cancer	0.0181	0.131	CbGeAlD
Doxepin—CYP3A4—Doxorubicin—muscle cancer	0.0151	0.0372	CbGbCtD
Doxepin—HRH4—bone marrow—muscle cancer	0.00675	0.0488	CbGeAlD
Doxepin—HTR2A—hindlimb—muscle cancer	0.00551	0.0399	CbGeAlD
Doxepin—HTR2A—appendage—muscle cancer	0.00473	0.0342	CbGeAlD
Doxepin—HRH2—cardiac atrium—muscle cancer	0.00336	0.0243	CbGeAlD
Doxepin—ADRA1B—renal system—muscle cancer	0.00327	0.0237	CbGeAlD
Doxepin—CHRM4—head—muscle cancer	0.00306	0.0222	CbGeAlD
Doxepin—CHRM4—testis—muscle cancer	0.00296	0.0214	CbGeAlD
Doxepin—HTR6—head—muscle cancer	0.00274	0.0198	CbGeAlD
Doxepin—HRH2—head—muscle cancer	0.00251	0.0181	CbGeAlD
Doxepin—CHRM5—head—muscle cancer	0.0024	0.0173	CbGeAlD
Doxepin—HTR2B—smooth muscle tissue—muscle cancer	0.00231	0.0167	CbGeAlD
Doxepin—ADRA1B—head—muscle cancer	0.00219	0.0158	CbGeAlD
Doxepin—ADRA1D—head—muscle cancer	0.00214	0.0155	CbGeAlD
Doxepin—CHRM3—smooth muscle tissue—muscle cancer	0.00208	0.015	CbGeAlD
Doxepin—CHRM3—renal system—muscle cancer	0.002	0.0145	CbGeAlD
Doxepin—HTR1A—renal system—muscle cancer	0.00199	0.0144	CbGeAlD
Doxepin—ORM1—bone marrow—muscle cancer	0.00199	0.0144	CbGeAlD
Doxepin—ADRA1A—renal system—muscle cancer	0.00184	0.0133	CbGeAlD
Doxepin—KCNH2—renal system—muscle cancer	0.00178	0.0128	CbGeAlD
Doxepin—ADRA2C—renal system—muscle cancer	0.00175	0.0127	CbGeAlD
Doxepin—HTR2B—tendon—muscle cancer	0.00174	0.0126	CbGeAlD
Doxepin—CHRM2—head—muscle cancer	0.00164	0.0119	CbGeAlD
Doxepin—HTR2B—vagina—muscle cancer	0.00161	0.0117	CbGeAlD
Doxepin—KCNH2—cardiac atrium—muscle cancer	0.00159	0.0115	CbGeAlD
Doxepin—HTR2C—head—muscle cancer	0.00158	0.0115	CbGeAlD
Doxepin—HTR2A—embryo—muscle cancer	0.00157	0.0114	CbGeAlD
Doxepin—ADRA2C—cardiac atrium—muscle cancer	0.00157	0.0113	CbGeAlD
Doxepin—CYP1A2—renal system—muscle cancer	0.00152	0.011	CbGeAlD
Doxepin—SLC6A4—head—muscle cancer	0.0015	0.0109	CbGeAlD
Doxepin—CHRM1—head—muscle cancer	0.0015	0.0108	CbGeAlD
Doxepin—HTR2B—head—muscle cancer	0.00149	0.0108	CbGeAlD
Doxepin—HRH1—smooth muscle tissue—muscle cancer	0.00148	0.0107	CbGeAlD
Doxepin—ADRA2C—tendon—muscle cancer	0.00137	0.00989	CbGeAlD
Doxepin—CYP2C19—vagina—muscle cancer	0.00135	0.00975	CbGeAlD
Doxepin—KCNH2—bone marrow—muscle cancer	0.00134	0.00971	CbGeAlD
Doxepin—CHRM3—head—muscle cancer	0.00134	0.00969	CbGeAlD
Doxepin—HTR1A—head—muscle cancer	0.00133	0.00965	CbGeAlD
Doxepin—SLC6A2—head—muscle cancer	0.00132	0.00957	CbGeAlD
Doxepin—CHRM3—testis—muscle cancer	0.00129	0.00936	CbGeAlD
Doxepin—KCNH2—vagina—muscle cancer	0.00129	0.0093	CbGeAlD
Doxepin—SLC6A2—testis—muscle cancer	0.00128	0.00924	CbGeAlD
Doxepin—ADRA2C—vagina—muscle cancer	0.00127	0.00917	CbGeAlD
Doxepin—ADRA2A—cardiac atrium—muscle cancer	0.00125	0.00905	CbGeAlD
Doxepin—HTR2A—smooth muscle tissue—muscle cancer	0.00123	0.00893	CbGeAlD
Doxepin—ADRA1A—head—muscle cancer	0.00123	0.00889	CbGeAlD
Doxepin—DRD2—head—muscle cancer	0.00121	0.00872	CbGeAlD
Doxepin—HTR2A—renal system—muscle cancer	0.00119	0.00859	CbGeAlD
Doxepin—KCNH2—head—muscle cancer	0.00119	0.00859	CbGeAlD
Doxepin—ADRA2C—head—muscle cancer	0.00117	0.00847	CbGeAlD
Doxepin—DRD2—testis—muscle cancer	0.00116	0.00842	CbGeAlD
Doxepin—KCNH2—testis—muscle cancer	0.00115	0.0083	CbGeAlD
Doxepin—ADRA2C—testis—muscle cancer	0.00113	0.00819	CbGeAlD
Doxepin—HRH1—tendon—muscle cancer	0.00111	0.00803	CbGeAlD
Doxepin—CYP3A4—renal system—muscle cancer	0.0011	0.00795	CbGeAlD
Doxepin—ADRA2A—tendon—muscle cancer	0.00109	0.00789	CbGeAlD
Doxepin—CYP2D6—renal system—muscle cancer	0.00108	0.00783	CbGeAlD
Doxepin—HRH1—vagina—muscle cancer	0.00103	0.00745	CbGeAlD
Doxepin—ABCB1—embryo—muscle cancer	0.00103	0.00744	CbGeAlD
Doxepin—ADRA2A—vagina—muscle cancer	0.00101	0.00732	CbGeAlD
Doxepin—HRH1—head—muscle cancer	0.000952	0.00688	CbGeAlD
Doxepin—ADRA2A—head—muscle cancer	0.000935	0.00676	CbGeAlD
Doxepin—Decreased appetite—Vincristine—muscle cancer	0.000934	0.00205	CcSEcCtD
Doxepin—Cough—Etoposide—muscle cancer	0.00093	0.00204	CcSEcCtD
Doxepin—HTR2A—tendon—muscle cancer	0.000928	0.00671	CbGeAlD
Doxepin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000927	0.00204	CcSEcCtD
Doxepin—Fatigue—Vincristine—muscle cancer	0.000926	0.00203	CcSEcCtD
Doxepin—Convulsion—Etoposide—muscle cancer	0.000924	0.00203	CcSEcCtD
Doxepin—Hypertension—Etoposide—muscle cancer	0.00092	0.00202	CcSEcCtD
Doxepin—HRH1—testis—muscle cancer	0.00092	0.00665	CbGeAlD
Doxepin—Constipation—Vincristine—muscle cancer	0.000919	0.00202	CcSEcCtD
Doxepin—Pain—Vincristine—muscle cancer	0.000919	0.00202	CcSEcCtD
Doxepin—Diplopia—Doxorubicin—muscle cancer	0.000918	0.00202	CcSEcCtD
Doxepin—Pain in extremity—Doxorubicin—muscle cancer	0.000918	0.00202	CcSEcCtD
Doxepin—Asthma—Methotrexate—muscle cancer	0.000917	0.00201	CcSEcCtD
Doxepin—Chest pain—Etoposide—muscle cancer	0.000908	0.00199	CcSEcCtD
Doxepin—Eosinophilia—Methotrexate—muscle cancer	0.000907	0.00199	CcSEcCtD
Doxepin—Migraine—Doxorubicin—muscle cancer	0.000904	0.00198	CcSEcCtD
Doxepin—ADRA2A—testis—muscle cancer	0.000903	0.00653	CbGeAlD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000901	0.00198	CcSEcCtD
Doxepin—Discomfort—Etoposide—muscle cancer	0.000897	0.00197	CcSEcCtD
Doxepin—Hypersensitivity—Dactinomycin—muscle cancer	0.000886	0.00195	CcSEcCtD
Doxepin—Gastrointestinal pain—Vincristine—muscle cancer	0.000878	0.00193	CcSEcCtD
Doxepin—Confusional state—Etoposide—muscle cancer	0.000877	0.00193	CcSEcCtD
Doxepin—Pancytopenia—Methotrexate—muscle cancer	0.00087	0.00191	CcSEcCtD
Doxepin—Infection—Etoposide—muscle cancer	0.000864	0.0019	CcSEcCtD
Doxepin—Ataxia—Doxorubicin—muscle cancer	0.000863	0.0019	CcSEcCtD
Doxepin—Asthenia—Dactinomycin—muscle cancer	0.000863	0.00189	CcSEcCtD
Doxepin—HTR2A—vagina—muscle cancer	0.000861	0.00622	CbGeAlD
Doxepin—Dysuria—Methotrexate—muscle cancer	0.000857	0.00188	CcSEcCtD
Doxepin—Thrombocytopenia—Etoposide—muscle cancer	0.000852	0.00187	CcSEcCtD
Doxepin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000852	0.00187	CcSEcCtD
Doxepin—Tachycardia—Etoposide—muscle cancer	0.000849	0.00187	CcSEcCtD
Doxepin—Body temperature increased—Vincristine—muscle cancer	0.000849	0.00186	CcSEcCtD
Doxepin—Abdominal pain—Vincristine—muscle cancer	0.000849	0.00186	CcSEcCtD
Doxepin—Skin disorder—Etoposide—muscle cancer	0.000845	0.00186	CcSEcCtD
Doxepin—Erectile dysfunction—Methotrexate—muscle cancer	0.000844	0.00185	CcSEcCtD
Doxepin—Hyperhidrosis—Etoposide—muscle cancer	0.000841	0.00185	CcSEcCtD
Doxepin—Hypokalaemia—Doxorubicin—muscle cancer	0.000836	0.00184	CcSEcCtD
Doxepin—Breast disorder—Doxorubicin—muscle cancer	0.00083	0.00182	CcSEcCtD
Doxepin—Anorexia—Etoposide—muscle cancer	0.000829	0.00182	CcSEcCtD
Doxepin—Diarrhoea—Dactinomycin—muscle cancer	0.000823	0.00181	CcSEcCtD
Doxepin—Pneumonia—Methotrexate—muscle cancer	0.000822	0.00181	CcSEcCtD
Doxepin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000821	0.0018	CcSEcCtD
Doxepin—Infestation NOS—Methotrexate—muscle cancer	0.000817	0.00179	CcSEcCtD
Doxepin—Drowsiness—Methotrexate—muscle cancer	0.000817	0.00179	CcSEcCtD
Doxepin—Infestation—Methotrexate—muscle cancer	0.000817	0.00179	CcSEcCtD
Doxepin—Hypotension—Etoposide—muscle cancer	0.000813	0.00179	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00081	0.00178	CcSEcCtD
Doxepin—Stomatitis—Methotrexate—muscle cancer	0.000797	0.00175	CcSEcCtD
Doxepin—HTR2A—head—muscle cancer	0.000795	0.00575	CbGeAlD
Doxepin—Influenza—Doxorubicin—muscle cancer	0.000794	0.00174	CcSEcCtD
Doxepin—Asthma—Doxorubicin—muscle cancer	0.000794	0.00174	CcSEcCtD
Doxepin—Hypersensitivity—Vincristine—muscle cancer	0.000791	0.00174	CcSEcCtD
Doxepin—Eosinophilia—Doxorubicin—muscle cancer	0.000786	0.00173	CcSEcCtD
Doxepin—Sweating—Methotrexate—muscle cancer	0.000783	0.00172	CcSEcCtD
Doxepin—Paraesthesia—Etoposide—muscle cancer	0.000781	0.00172	CcSEcCtD
Doxepin—ABCB1—renal system—muscle cancer	0.000779	0.00563	CbGeAlD
Doxepin—Dyspnoea—Etoposide—muscle cancer	0.000776	0.0017	CcSEcCtD
Doxepin—Somnolence—Etoposide—muscle cancer	0.000774	0.0017	CcSEcCtD
Doxepin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000773	0.0017	CcSEcCtD
Doxepin—Asthenia—Vincristine—muscle cancer	0.000771	0.00169	CcSEcCtD
Doxepin—HTR2A—testis—muscle cancer	0.000768	0.00555	CbGeAlD
Doxepin—Vomiting—Dactinomycin—muscle cancer	0.000764	0.00168	CcSEcCtD
Doxepin—Bronchitis—Doxorubicin—muscle cancer	0.000763	0.00168	CcSEcCtD
Doxepin—Agranulocytosis—Methotrexate—muscle cancer	0.000763	0.00167	CcSEcCtD
Doxepin—Rash—Dactinomycin—muscle cancer	0.000758	0.00166	CcSEcCtD
Doxepin—Decreased appetite—Etoposide—muscle cancer	0.000756	0.00166	CcSEcCtD
Doxepin—Pancytopenia—Doxorubicin—muscle cancer	0.000754	0.00166	CcSEcCtD
Doxepin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000751	0.00165	CcSEcCtD
Doxepin—Fatigue—Etoposide—muscle cancer	0.00075	0.00165	CcSEcCtD
Doxepin—Pain—Etoposide—muscle cancer	0.000744	0.00163	CcSEcCtD
Doxepin—Constipation—Etoposide—muscle cancer	0.000744	0.00163	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—muscle cancer	0.000742	0.00163	CcSEcCtD
Doxepin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000738	0.00162	CcSEcCtD
Doxepin—Diarrhoea—Vincristine—muscle cancer	0.000735	0.00161	CcSEcCtD
Doxepin—Hepatitis—Methotrexate—muscle cancer	0.000734	0.00161	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—muscle cancer	0.000733	0.00161	CcSEcCtD
Doxepin—Pharyngitis—Methotrexate—muscle cancer	0.000728	0.0016	CcSEcCtD
Doxepin—Urinary tract disorder—Methotrexate—muscle cancer	0.000724	0.00159	CcSEcCtD
Doxepin—CYP2D6—head—muscle cancer	0.000724	0.00524	CbGeAlD
Doxepin—Weight increased—Doxorubicin—muscle cancer	0.000722	0.00159	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—muscle cancer	0.000719	0.00158	CcSEcCtD
Doxepin—Feeling abnormal—Etoposide—muscle cancer	0.000717	0.00157	CcSEcCtD
Doxepin—Nausea—Dactinomycin—muscle cancer	0.000714	0.00157	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—muscle cancer	0.000712	0.00156	CcSEcCtD
Doxepin—Gastrointestinal pain—Etoposide—muscle cancer	0.000712	0.00156	CcSEcCtD
Doxepin—Dizziness—Vincristine—muscle cancer	0.00071	0.00156	CcSEcCtD
Doxepin—Infestation—Doxorubicin—muscle cancer	0.000708	0.00155	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—muscle cancer	0.000708	0.00155	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—muscle cancer	0.000708	0.00155	CcSEcCtD
Doxepin—CYP2D6—testis—muscle cancer	0.0007	0.00506	CbGeAlD
Doxepin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000694	0.00152	CcSEcCtD
Doxepin—Urticaria—Etoposide—muscle cancer	0.000691	0.00152	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—muscle cancer	0.00069	0.00151	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—muscle cancer	0.00069	0.00151	CcSEcCtD
Doxepin—Abdominal pain—Etoposide—muscle cancer	0.000688	0.00151	CcSEcCtD
Doxepin—Body temperature increased—Etoposide—muscle cancer	0.000688	0.00151	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—muscle cancer	0.000688	0.00151	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—muscle cancer	0.000686	0.00151	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—muscle cancer	0.000684	0.0015	CcSEcCtD
Doxepin—Vomiting—Vincristine—muscle cancer	0.000683	0.0015	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—muscle cancer	0.000681	0.0015	CcSEcCtD
Doxepin—Sweating—Doxorubicin—muscle cancer	0.000678	0.00149	CcSEcCtD
Doxepin—Rash—Vincristine—muscle cancer	0.000677	0.00149	CcSEcCtD
Doxepin—Dermatitis—Vincristine—muscle cancer	0.000677	0.00149	CcSEcCtD
Doxepin—Headache—Vincristine—muscle cancer	0.000673	0.00148	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000669	0.00147	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—muscle cancer	0.000666	0.00146	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—muscle cancer	0.000664	0.00146	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—muscle cancer	0.000663	0.00146	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—muscle cancer	0.000661	0.00145	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—muscle cancer	0.00066	0.00145	CcSEcCtD
Doxepin—Chills—Methotrexate—muscle cancer	0.000658	0.00145	CcSEcCtD
Doxepin—Alopecia—Methotrexate—muscle cancer	0.000648	0.00142	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—muscle cancer	0.000647	0.00142	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—muscle cancer	0.000643	0.00141	CcSEcCtD
Doxepin—Hypersensitivity—Etoposide—muscle cancer	0.000641	0.00141	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—muscle cancer	0.000639	0.0014	CcSEcCtD
Doxepin—Erythema—Methotrexate—muscle cancer	0.000639	0.0014	CcSEcCtD
Doxepin—Nausea—Vincristine—muscle cancer	0.000638	0.0014	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—muscle cancer	0.000635	0.0014	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000632	0.00139	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—muscle cancer	0.00063	0.00138	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—muscle cancer	0.000627	0.00138	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—muscle cancer	0.000626	0.00137	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—muscle cancer	0.000625	0.00137	CcSEcCtD
Doxepin—Asthenia—Etoposide—muscle cancer	0.000624	0.00137	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000624	0.00137	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—muscle cancer	0.000623	0.00137	CcSEcCtD
Doxepin—Back pain—Methotrexate—muscle cancer	0.000618	0.00136	CcSEcCtD
Doxepin—Pruritus—Etoposide—muscle cancer	0.000616	0.00135	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—muscle cancer	0.000602	0.00132	CcSEcCtD
Doxepin—Diarrhoea—Etoposide—muscle cancer	0.000595	0.00131	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—muscle cancer	0.000594	0.0013	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—muscle cancer	0.000593	0.0013	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—muscle cancer	0.000592	0.0013	CcSEcCtD
Doxepin—Anaemia—Methotrexate—muscle cancer	0.00059	0.0013	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—muscle cancer	0.00059	0.00129	CcSEcCtD
Doxepin—Flushing—Doxorubicin—muscle cancer	0.00059	0.00129	CcSEcCtD
Doxepin—ABCB1—bone marrow—muscle cancer	0.000589	0.00426	CbGeAlD
Doxepin—Angiopathy—Doxorubicin—muscle cancer	0.000576	0.00127	CcSEcCtD
Doxepin—Malaise—Methotrexate—muscle cancer	0.000576	0.00126	CcSEcCtD
Doxepin—Dizziness—Etoposide—muscle cancer	0.000575	0.00126	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—muscle cancer	0.000574	0.00126	CcSEcCtD
Doxepin—Vertigo—Methotrexate—muscle cancer	0.000574	0.00126	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—muscle cancer	0.000572	0.00126	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—muscle cancer	0.000572	0.00126	CcSEcCtD
Doxepin—Chills—Doxorubicin—muscle cancer	0.00057	0.00125	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—muscle cancer	0.000567	0.00125	CcSEcCtD
Doxepin—ABCB1—vagina—muscle cancer	0.000564	0.00408	CbGeAlD
Doxepin—Alopecia—Doxorubicin—muscle cancer	0.000561	0.00123	CcSEcCtD
Doxepin—Cough—Methotrexate—muscle cancer	0.000557	0.00122	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—muscle cancer	0.000557	0.00122	CcSEcCtD
Doxepin—Convulsion—Methotrexate—muscle cancer	0.000553	0.00122	CcSEcCtD
Doxepin—Vomiting—Etoposide—muscle cancer	0.000553	0.00122	CcSEcCtD
Doxepin—Erythema—Doxorubicin—muscle cancer	0.000553	0.00121	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—muscle cancer	0.000553	0.00121	CcSEcCtD
Doxepin—Rash—Etoposide—muscle cancer	0.000549	0.0012	CcSEcCtD
Doxepin—Dermatitis—Etoposide—muscle cancer	0.000548	0.0012	CcSEcCtD
Doxepin—Headache—Etoposide—muscle cancer	0.000545	0.0012	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—muscle cancer	0.000545	0.0012	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—muscle cancer	0.000544	0.00119	CcSEcCtD
Doxepin—Chest pain—Methotrexate—muscle cancer	0.000544	0.00119	CcSEcCtD
Doxepin—Myalgia—Methotrexate—muscle cancer	0.000544	0.00119	CcSEcCtD
Doxepin—Tension—Doxorubicin—muscle cancer	0.000543	0.00119	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—muscle cancer	0.000542	0.00119	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00054	0.00119	CcSEcCtD
Doxepin—Discomfort—Methotrexate—muscle cancer	0.000537	0.00118	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—muscle cancer	0.000537	0.00118	CcSEcCtD
Doxepin—Back pain—Doxorubicin—muscle cancer	0.000535	0.00117	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—muscle cancer	0.000532	0.00117	CcSEcCtD
Doxepin—Confusional state—Methotrexate—muscle cancer	0.000526	0.00115	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—muscle cancer	0.000521	0.00114	CcSEcCtD
Doxepin—ABCB1—head—muscle cancer	0.000521	0.00377	CbGeAlD
Doxepin—Infection—Methotrexate—muscle cancer	0.000518	0.00114	CcSEcCtD
Doxepin—Nausea—Etoposide—muscle cancer	0.000517	0.00114	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000513	0.00113	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—muscle cancer	0.000511	0.00112	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—muscle cancer	0.000511	0.00112	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—muscle cancer	0.00051	0.00112	CcSEcCtD
Doxepin—Agitation—Doxorubicin—muscle cancer	0.000508	0.00112	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—muscle cancer	0.000506	0.00111	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—muscle cancer	0.000504	0.00111	CcSEcCtD
Doxepin—ABCB1—testis—muscle cancer	0.000503	0.00364	CbGeAlD
Doxepin—Malaise—Doxorubicin—muscle cancer	0.000499	0.0011	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—muscle cancer	0.000497	0.00109	CcSEcCtD
Doxepin—Anorexia—Methotrexate—muscle cancer	0.000497	0.00109	CcSEcCtD
Doxepin—Syncope—Doxorubicin—muscle cancer	0.000496	0.00109	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—muscle cancer	0.000495	0.00109	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—muscle cancer	0.000489	0.00107	CcSEcCtD
Doxepin—Hypotension—Methotrexate—muscle cancer	0.000487	0.00107	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—muscle cancer	0.000486	0.00107	CcSEcCtD
Doxepin—Cough—Doxorubicin—muscle cancer	0.000483	0.00106	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—muscle cancer	0.000479	0.00105	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—muscle cancer	0.000477	0.00105	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000475	0.00104	CcSEcCtD
Doxepin—Insomnia—Methotrexate—muscle cancer	0.000471	0.00104	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—muscle cancer	0.000471	0.00103	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—muscle cancer	0.000471	0.00103	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—muscle cancer	0.000471	0.00103	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—muscle cancer	0.000469	0.00103	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—muscle cancer	0.000468	0.00103	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000468	0.00103	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—muscle cancer	0.000465	0.00102	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—muscle cancer	0.000465	0.00102	CcSEcCtD
Doxepin—Somnolence—Methotrexate—muscle cancer	0.000463	0.00102	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—muscle cancer	0.00046	0.00101	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—muscle cancer	0.000459	0.00101	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—muscle cancer	0.000455	0.000999	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—muscle cancer	0.000453	0.000995	CcSEcCtD
Doxepin—Oedema—Doxorubicin—muscle cancer	0.000451	0.000991	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00045	0.000988	CcSEcCtD
Doxepin—Fatigue—Methotrexate—muscle cancer	0.000449	0.000987	CcSEcCtD
Doxepin—Infection—Doxorubicin—muscle cancer	0.000448	0.000985	CcSEcCtD
Doxepin—Pain—Methotrexate—muscle cancer	0.000446	0.000979	CcSEcCtD
Doxepin—Shock—Doxorubicin—muscle cancer	0.000444	0.000975	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—muscle cancer	0.000443	0.000972	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000442	0.00097	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—muscle cancer	0.00044	0.000967	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—muscle cancer	0.000438	0.000963	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000436	0.000958	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—muscle cancer	0.00043	0.000945	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—muscle cancer	0.000429	0.000943	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000426	0.000936	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—muscle cancer	0.000422	0.000926	CcSEcCtD
Doxepin—Urticaria—Methotrexate—muscle cancer	0.000414	0.000909	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—muscle cancer	0.000412	0.000905	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—muscle cancer	0.000412	0.000905	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000411	0.000903	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—muscle cancer	0.000408	0.000896	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—muscle cancer	0.000405	0.00089	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—muscle cancer	0.000402	0.000884	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—muscle cancer	0.000401	0.000881	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—muscle cancer	0.000397	0.000872	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—muscle cancer	0.000392	0.000862	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00039	0.000856	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—muscle cancer	0.000389	0.000855	CcSEcCtD
Doxepin—Pain—Doxorubicin—muscle cancer	0.000386	0.000848	CcSEcCtD
Doxepin—Constipation—Doxorubicin—muscle cancer	0.000386	0.000848	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—muscle cancer	0.000384	0.000843	CcSEcCtD
Doxepin—Asthenia—Methotrexate—muscle cancer	0.000374	0.000821	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—muscle cancer	0.000372	0.000817	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000369	0.00081	CcSEcCtD
Doxepin—Pruritus—Methotrexate—muscle cancer	0.000369	0.00081	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—muscle cancer	0.000359	0.000787	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—muscle cancer	0.000357	0.000784	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—muscle cancer	0.000357	0.000784	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—muscle cancer	0.000357	0.000783	CcSEcCtD
Doxepin—Dizziness—Methotrexate—muscle cancer	0.000345	0.000757	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—muscle cancer	0.000333	0.00073	CcSEcCtD
Doxepin—Vomiting—Methotrexate—muscle cancer	0.000331	0.000728	CcSEcCtD
Doxepin—Rash—Methotrexate—muscle cancer	0.000329	0.000722	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—muscle cancer	0.000328	0.000721	CcSEcCtD
Doxepin—Headache—Methotrexate—muscle cancer	0.000327	0.000717	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—muscle cancer	0.000324	0.000711	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—muscle cancer	0.000319	0.000701	CcSEcCtD
Doxepin—Nausea—Methotrexate—muscle cancer	0.00031	0.00068	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—muscle cancer	0.000309	0.000678	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—muscle cancer	0.000298	0.000655	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—muscle cancer	0.000287	0.00063	CcSEcCtD
Doxepin—Rash—Doxorubicin—muscle cancer	0.000285	0.000625	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—muscle cancer	0.000284	0.000624	CcSEcCtD
Doxepin—Headache—Doxorubicin—muscle cancer	0.000283	0.000621	CcSEcCtD
Doxepin—Nausea—Doxorubicin—muscle cancer	0.000268	0.000589	CcSEcCtD
